AMLX Overview
Upcoming Projects (AMLX)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (AMLX)
-
Quarterly Survey: ALS Treatments and Biogen's Qalsody (tofersen) October 2023
Tickers: BIIB, Mitsubishi Tanabe Pharma America, AMLX
Executed On: Oct 31, 2023 at 11:41 AM EDT -
A Second Opinion: Checking in with a prescriber of Amylyx's Relyvrio for the slowing of ALS progression.
Ticker: AMLX
Executed On: Oct 19, 2023 at 02:00 PM EDT -
Checking in with a prescriber of Amylyx's Relyvrio for the slowing of ALS progression.
Ticker: AMLX
Executed On: Sep 15, 2023 at 03:30 PM EDT -
Discussing the recent FDA Approval of Relyvrio (AMX0035) for treatment of adults with amyotrophic lateral sclerosis (ALS)
Ticker: AMLX
Executed On: Oct 24, 2022 at 01:00 PM EDT -
A Second View: Examining Amylyx' AMX0035 in ALS before the March 30th FDA ADCOM
Ticker: AMLX
Executed On: Mar 29, 2022 at 04:00 PM EDT -
Examining Amylyx' AMX0035 in ALS before the March 30th FDA ADCOM
Ticker: AMLX
Executed On: Mar 29, 2022 at 12:00 PM EDT -
Discussing new treatments for ALS with members of The ALS Association
Tickers: AMLX, IONS
Executed On: Mar 18, 2022 at 03:00 PM EDT
Upcoming & Overdue Catalysts (AMLX)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (AMLX)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
